Genetic profiling and individualized assessment of fracture risk

Nature Reviews Endocrinology

Volumn 9, Issue 3, 2013, Pages 153-161

  Nguyen, Tuan V ^a   Eisman, John A ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; FRACTURE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

BONE DENSITY; FEMALE; FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; ODDS RATIO; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOME;

EID: 84875533919     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.3     Document Type: Review

References (62)

1. Nguyen, N. D., Ahlborg, H. G., Center, J. R., Eisman, J. A. & Nguyen, T. V. Residual lifetime risk of fractures in women and men. J. Bone Miner. Res. 22, 781-788 (2007).
2. Cummings, S. R., Black, D. M. & Rubin, S. M. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch. Intern. Med. 149, 2445-2448 (1989).
3. Shortt, N. L. & Robinson, C. M. Mortality after low-energy fractures in patients aged at least 45 years old. J. Orthop. Trauma 19, 396-400 (2005).
4. Bliuc, D. et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301, 513-521 (2009).
5. Center, J. R., Bliuc, D., Nguyen, T. V. & Eisman, J. A. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297, 387-394 (2007).
6. Center, J. R., Nguyen, T. V., Schneider, D., Sambrook, P. N. & Eisman, J. A. Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 353, 878-882 (1999).
7. Johnell, O. et al. Predictive value of BMD for hip and other fractures. J. Bone Miner. Res. 20, 1185-1194 (2005).
8. Nguyen, N. D., Pongchaiyakul, C., Center, J. R., Eisman, J. A. & Nguyen, T. V. Identification of high-risk individuals for hip fracture: A 14-year prospective study. J. Bone Miner. Res. 20, 1921-1928 (2005).
9. Leslie, W. D., Lix, L. M., Tsang, J. F. & Caetano, P. A. Single-site vs multisite bone density measurement for fracture prediction. Arch. Intern. Med. 167, 1641-1647 (2007).
10. Delmas, P. D. Treatment of postmenopausal osteoporosis. Lancet 359, 2018-2026 (2002).
11. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis [online], http://www.nof.org/file/nof/public/content/ file/344/upload/159.pdf (2010).
12. Rose, G. Sick individuals and sick populations. Int. J. Epidemiol. 14, 427-432 (1985).
13. Nguyen, N. D., Eisman, J. A., Center, J. R. & Nguyen, T. V. Risk factors for fracture in nonosteoporotic men and women. J. Clin. Endocrinol. Metab. 92, 955-962 (2007).
14. Nguyen, T. et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ 307, 1111-1115 (1993).
15. Nguyen, T. V., Howard, G. M., Kelly, P. J. & Eisman, J. A. Bone mass, lean mass, and fat mass: Same genes or same environments? Am. J. Epidemiol. 147, 3-16 (1998).
16. Pocock, N. A. et al. Genetic determinants of bone mass in adults. A twin study. J. Clin. Invest. 80, 706-710 (1987).
17. Makovey, J., Nguyen, T. V., Naganathan, V., Wark, J. D. & Sambrook, P. N. Genetic effects on bone loss in peri- and postmenopausal women: A longitudinal twin study. J. Bone Miner. Res. 22, 1773-1780 (2007).
18. Howard, G. M., Nguyen, T. V., Harris, M., Kelly, P. J. & Eisman, J. A. Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: A twin study. J. Bone Miner. Res. 13, 1318-1327 (1998).
19. Tokita, A. et al. Genetic influences on type I collagen synthesis and degradation: Further evidence for genetic regulation of bone turnover. J. Clin. Endocrinol. Metab. 78, 1461-1466 (1994).
20. Deng, H. W. et al. Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture. J. Bone Miner. Res. 15, 1243-1252 (2000).
21. Michaëlsson, K., Melhus, H., Ferm, H., Ahlbom, A. & Pedersen, N. L. Genetic liability to fractures in the elderly. Arch. Intern. Med. 165, 1825-1830 (2005).
22. Cummings, S. R. et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 332, 767-773 (1995).
23. Seeman, E. et al. Reduced bone mass in daughters of women with osteoporosis. N. Engl. J. Med. 320, 554-558 (1989).
24. Seeman, E., Tsalamandris, C., Formica, C., Hopper, J. L. & McKay, J. Reduced femoral neck bone density in the daughters of women with hip fractures: The role of low peak bone density in the pathogenesis of osteoporosis. J. Bone Miner. Res. 9, 739-743 (1994).
25. Evans, R. A. et al. Bone mass is low in relatives of osteoporotic patients. Ann. Intern. Med. 109, 870-873 (1988).
26. Kanis, J. A. et al. A family history of fracture and fracture risk: A meta-analysis. Bone 35, 1029-1037 (2004).
27. Ralston, S. H. & Uitterlinden, A. G. Genetics of osteoporosis. Endocr. Rev. 31, 629-662 (2010).
28. Huang, Q. Y., Recker, R. R. & Deng, H. W. Searching for osteoporosis genes in the post-genome era: Progress and challenges. Osteoporos. Int. 14, 701-715 (2003).
29. Nguyen, T. V. Pharmacogenetics of anti-resorptive therapy efficacy: A Bayesian interpretation. Osteoporos. Int. 16, 857-860 (2005).
30. Campbell, H. & Rudan, I. Interpretation of genetic association studies in complex disease. Pharmacogenomics J. 2, 349-360 (2002).
31. Ioannidis, J. P. A. Why most published research findings are false. PLoS Med. 2, e124 (2005).
32. Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108 (2005).
33. Burton, P. R. et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
34. Kiel, D. P. et al. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med. Genet. 8 (Suppl. 1), 14 (2007).
35. Styrkarsdottir, U. et al. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 358, 2355-2365 (2008).
36. Richards, J. B. et al. Bone mineral density, osteoporosis, and osteoporotic fractures: A genome-wide association study. Lancet 371, 1505-1512 (2008).
37. Richards, J. B., Zheng, H. F. & Spector, T. D. Genetics of osteoporosis from genome-wide association studies: Advances and challenges. Nat. Rev. Genet. 13, 576-588 (2012).
38. Rivadeneira, F. et al. Twenty bone?mineral?density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 41, 1199-1206 (2009).
39. Richards, J. B. et al. Collaborative meta-analysis: Associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann. Intern. Med. 151, 528-537 (2009).
40. Estrada, K. et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet.44, 491-501 (2012).
41. Pepe, M. S., Janes, H., Longton, G., Leisenring, W. & Newcomb, P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am. J. Epidemiol. 159, 882-890 (2004).
42. Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36 (1982).
43. Bolland, M. J., Grey, A. & Reid, I. R. Re: The calcium scare: what would Austin Bradford Hill have thought? Osteoporos. Int. 22, 3079-3080 (2011).
44. Pencina, M. J., D'Agostino, R. B. Sr, D'Agostino, R. B. Jr & Vasan, R. S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157-172 (2008).
45. Cook, N. R. Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin. Chem. 54, 17-23 (2008).
46. Pepe, M. S., Gu, J. W. & Morris, D. E. The potential of genes and other markers to inform about risk. Cancer Epidemiol. Biomarkers Prev. 19, 655-665.
47. Nguyen, T. V. et al. Contribution of the collagen I alpha1 and vitamin D receptor genes to the risk of hip fracture in elderly women. J. Clin. Endocrinol. Metab. 90, 6575-6579 (2005).
48. Tran, B. N., Nguyen, N. D., Center, J. R., Eisman, J. A. & Nguyen, T. V. Enhancement of absolute fracture risk prognosis with genetic marker: The collagen I ? 1 gene. Calcif. Tissue Int. 85, 379-388 (2009).
49. Bacon, C. J. et al. Prevalent dietary supplement use in older New Zealand men. N. Z. Med. J. 124, 55-62 (2011).
50. Wray, N. R., Yang, J., Goddard, M. E. & Visscher, P. M. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 6, e1000864 (2010).
51. Nguyen, N. D., Frost, S. A., Center, J. R., Eisman, J. A. & Nguyen, T. V. Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos. Int. 18, 1109-1117 (2007).
52. Nguyen, N. D., Frost, S. A., Center, J. R., Eisman, J. A. & Nguyen, T. V. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos. Int. 19, 1431-1444 (2008).
53. Kanis, J. A., Johnell, O., Oden, A., Johansson, H. & McCloskey, E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 19, 385-397 (2008).
54. Tran, B. N. et al. Genetic profiling and individualized prognosis of fracture. J. Bone Miner. Res.26, 414-419 (2011).
55. Bolland, M. J., Grey, A. & Reid, I. R. Authors' response to editorial. BMJ 342, d3520 (2011).
56. Zuk, O., Hechter, E., Sunyaev, S. R. & Lander, E. S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl Acad. Sci. USA 109, 1193-1198 (2012).
57. Center, J. R., Nguyen, T. V., Sambrook, P. N. & Eisman, J. A. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J. Clin. Endocrinol. Metab. 84, 3626-3635 (1999).
58. Nguyen, T. V., Center, J. R., Sambrook, P. N. & Eisman, J. A. Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: The Dubbo Osteoporosis Epidemiology Study. Am. J. Epidemiol. 153, 587-595 (2001).
59. Nguyen, T. V. et al. Lifestyle factors and bone density in the elderly: Implications for osteoporosis prevention. J. Bone Miner. Res. 9, 1339-1346 (1994).
60. Delmas, P. D., Rizzoli, R., Cooper, C. & Reginster, J. Y. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos. Int. 16, 1-5 (2005).
61. Nguyen, N. D., Eisman, J. A. & Nguyen, T. V. Anti-hip fracture efficacy of bisphosphonates: A Bayesian analysis of clinical trials. J. Bone Miner. Res. 21, 340-349 (2006).
62. McCloskey, E. et al. Efficacy of clodronate on fracture risk in women selected by 10-year fracture probability. J. Bone Miner. Res. 22 (Suppl. 1), S131 (2007).